Cargando…
Aromatase 2004, Edinburgh, UK, 6-8 September 2004
Aromatase is the key enzyme involved in oestrogen biosynthesis. Oestrogens not only influence normal development and function but are also implicated in the aetiology and progression of many diseases. Over recent years rational drug design programmes have led to the development of agents that specif...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064110/ https://www.ncbi.nlm.nih.gov/pubmed/15642156 http://dx.doi.org/10.1186/bcr964 |
_version_ | 1782123292715384832 |
---|---|
author | Miller, William R Larionov, Alexey |
author_facet | Miller, William R Larionov, Alexey |
author_sort | Miller, William R |
collection | PubMed |
description | Aromatase is the key enzyme involved in oestrogen biosynthesis. Oestrogens not only influence normal development and function but are also implicated in the aetiology and progression of many diseases. Over recent years rational drug design programmes have led to the development of agents that specifically and potently inhibit aromatase. The multidisciplinary international symposium Aromatase 2004 provided a forum in which basic scientists, translational researchers and practising clinicians reviewed latest results, exchanged opinions, and defined future needs for the regulation of oestrogen biosynthesis and the use of aromatase inhibitors. |
format | Text |
id | pubmed-1064110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-10641102005-03-11 Aromatase 2004, Edinburgh, UK, 6-8 September 2004 Miller, William R Larionov, Alexey Breast Cancer Res Meeting Report Aromatase is the key enzyme involved in oestrogen biosynthesis. Oestrogens not only influence normal development and function but are also implicated in the aetiology and progression of many diseases. Over recent years rational drug design programmes have led to the development of agents that specifically and potently inhibit aromatase. The multidisciplinary international symposium Aromatase 2004 provided a forum in which basic scientists, translational researchers and practising clinicians reviewed latest results, exchanged opinions, and defined future needs for the regulation of oestrogen biosynthesis and the use of aromatase inhibitors. BioMed Central 2005 2004-11-02 /pmc/articles/PMC1064110/ /pubmed/15642156 http://dx.doi.org/10.1186/bcr964 Text en Copyright © 2004 BioMed Central Ltd |
spellingShingle | Meeting Report Miller, William R Larionov, Alexey Aromatase 2004, Edinburgh, UK, 6-8 September 2004 |
title | Aromatase 2004, Edinburgh, UK, 6-8 September 2004 |
title_full | Aromatase 2004, Edinburgh, UK, 6-8 September 2004 |
title_fullStr | Aromatase 2004, Edinburgh, UK, 6-8 September 2004 |
title_full_unstemmed | Aromatase 2004, Edinburgh, UK, 6-8 September 2004 |
title_short | Aromatase 2004, Edinburgh, UK, 6-8 September 2004 |
title_sort | aromatase 2004, edinburgh, uk, 6-8 september 2004 |
topic | Meeting Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064110/ https://www.ncbi.nlm.nih.gov/pubmed/15642156 http://dx.doi.org/10.1186/bcr964 |
work_keys_str_mv | AT millerwilliamr aromatase2004edinburghuk68september2004 AT larionovalexey aromatase2004edinburghuk68september2004 |